Matches in Nanopublications for { ?s ?p "[We defined clinically relevant time points for NPM1(mut) MRD assessment that allow for the identification of patients with AML who are at high risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_assertion description "[We defined clinically relevant time points for NPM1(mut) MRD assessment that allow for the identification of patients with AML who are at high risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP597813.RArze4YsEX_NYlxE_x34g_P77KmyxKdG_u9GGoAtdXsB0130_provenance.
- NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_assertion description "[We defined clinically relevant time points for NPM1(mut) MRD assessment that allow for the identification of patients with AML who are at high risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892738.RAmZNwPvIakp1BLjfTlzKWS2A8SsYoq9ew4eTNxaAKDEM130_provenance.
- NP892742.RAuZokGmOzHcBXRbvZzI8e7rm50pB4ctrHQ6BQdvgcV7k130_assertion description "[We defined clinically relevant time points for NPM1(mut) MRD assessment that allow for the identification of patients with AML who are at high risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892742.RAuZokGmOzHcBXRbvZzI8e7rm50pB4ctrHQ6BQdvgcV7k130_provenance.